Use of generic medicines by the brazilian population: an evaluation of pnaum 2014

Show simple item record

dc.contributor.author Bertoldi, Andrea Damaso
dc.contributor.author Dourado Arrais, Paulo Sergio
dc.contributor.author Leao Tavares, Noemia Urruth
dc.contributor.author Ramos, Luiz Roberto [UNIFESP]
dc.contributor.author Luiza, Vera Lucia
dc.contributor.author Mengue, Sotero Serrate
dc.contributor.author Dal-Pizzol, Tatiane da Silva
dc.contributor.author Farias, Mareni Rocha
dc.contributor.author Oliveira, Maria Auxiliadora
dc.date.accessioned 2019-01-21T10:29:35Z
dc.date.available 2019-01-21T10:29:35Z
dc.date.issued 2016
dc.identifier http://dx.doi.org/10.1590/s1518-8787.2016050006120
dc.identifier.citation Revista De Saude Publica. Sao paulo, v. 50, n. 2, p. 11s, 2016.
dc.identifier.issn 0034-8910
dc.identifier.uri http://repositorio.unifesp.br/handle/11600/49278
dc.description.abstract OBJECTIVE: To analyze the existence of differences in the use of generic medicines in Brazil according to demographic and socioeconomic variables and acquisition sources of the medicines. METHODS: Population-based cross-sectional study, conducted with data from the Pesquisa Nacional de Acesso, Utilizacao e Promocao do Uso Racional de Medicamentos (PNAUM - National Survey on Access, Use and Promotion of Rational Use of Medicines). Data collection took place between September, 2013 and February, 2014 in homes of Brazilian cities (urban area). The use of medicines has been investigated in relation to the treatment of chronic diseases and, in the case of acute events, regarding use over the previous 15 days. Generics were identified by visualization of packaging presented by the users of the medicines. The independent variables used were sex, age, education level, economic class, and region of the Country. The statistical significance of differences between the groups was evaluated by Pearson's Chi-squared test, considering a 5% significance level. RESULTS: The prevalence of generic medicines use was 45.5% (95% CI 43.7-47.3). There was no difference considering education level. The prevalence was higher in females (47.0% en
dc.description.abstract 95% CI 44.9-49.0) than in males (43.1% en
dc.description.abstract 95% CI 40.5-45.8), and were higher with increasing age. Generic medicines were more used in the economic class C (47.0% en
dc.description.abstract 95% CI 44.9-49.1) and in the South (50.6% en
dc.description.abstract 95% CI 46.6-54.6) and Southeast (49.9% en
dc.description.abstract 95% CI 46.8-53.0) regions. Generics accounted for 37.3% of the medicines provided by the Brazilian Unified Health System. CONCLUSIONS: Currently, there is a choice of purchase or free provision by the Brazilian Unified Health System, characterized by quality assurance and reduced price regarding branded medicines considered as reference. In the private market, a considerable part of the population is choosing generic medicines thanks to the availability of this option for virtually all medicines most used by the population. en
dc.description.sponsorship Department of Pharmaceutical Services and Strategic Health Supplies (DAF) of the Secretariat of Science, Technology and Strategic Inputs of the Ministry of Health (SCTIE/MS) [25000.111834/2]
dc.description.sponsorship Department of Science and Technology (DECIT) of the Secretariat of Science, Technology and Strategic Inputs of the Ministry of Health (SCTIE/MS) [25000.111834/2]
dc.format.extent 11s
dc.language.iso eng
dc.publisher Iop Publishing Ltd
dc.relation.ispartof Revista De Saude Publica
dc.rights Acesso aberto
dc.subject Sao-Paulo en
dc.subject Medication en
dc.subject Adults en
dc.subject Campinas en
dc.subject Drugs en
dc.title Use of generic medicines by the brazilian population: an evaluation of pnaum 2014 en
dc.title Utilização de medicamentos genéricos na população brasileira: uma avaliação da PNAUM 2014 pt
dc.type Artigo
dc.description.affiliation Departamento de Medicina Social. Faculdade de Medicina. Universidade Federal de Pelotas. Pelotas, RS, Brasil
dc.description.affiliation Departamento de Farmácia. Faculdade de Farmácia, Odontologia e Enfermagem. Universidade Federal do Ceará. Fortaleza, CE, Brasil
dc.description.affiliation Departamento de Farmácia. Faculdade de Ciências da Saúde. Universidade de Brasília. Brasília, DF, Brasil
dc.description.affiliation Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.affiliation Departamento de Política de Medicamentos e Assistência Farmacêutica. Escola Nacional de Saúde Pública Sérgio Arouca. Fundação Oswaldo Cruz. Rio de Janeiro, RJ, Brasil
dc.description.affiliation Programa de Pós-Graduação em Epidemiologia. Faculdade de Medicina. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliation Departamento de Produção e Controle de Medicamentos. Faculdade de Farmácia. Universidade Federal do Rio Grande do Sul. Porto Alegre, RS, Brasil
dc.description.affiliation Departamento de Ciências Farmacêuticas. Centro de Ciências da Saúde. Universidade Federal de Santa Catarina. Florianópolis, SC, Brasil
dc.description.affiliationUnifesp Departamento de Medicina Preventiva. Escola Paulista de Medicina. Universidade Federal de São Paulo. São Paulo, SP, Brasil
dc.description.sponsorshipID SCTIE/MS: 25000.111834/2
dc.identifier.file S0034-89102016000300309.pdf
dc.identifier.scielo S0034-89102016000300309
dc.identifier.doi 10.1590/S1518-8787.2016050006120
dc.description.source Web of Science
dc.identifier.wos WOS:000391447400005



File

File Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Search


Browse

Statistics

My Account